Inhibition of E6-induced degradation of its cellular substrates by novel blocking peptides.
about
Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein.Therapy of human papillomavirus-related diseasePapillomavirus E6 oncoproteins.Peptide interactions stabilize and restructure human papillomavirus type 16 E6 to interact with p53Pitx2a binds to human papillomavirus type 18 E6 protein and inhibits E6-mediated P53 degradation in HeLa cells.Emerging drugs to treat squamous cell carcinomas of the head and neck.Small molecule inhibitors of human papillomavirus protein - protein interactions.PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6Recent advances in the search for antiviral agents against human papillomaviruses.Cellular binding partners of the human papillomavirus E6 protein.The interaction between human papillomavirus type 16 and FADD is mediated by a novel E6 binding domain.Molecular characterization of head and neck cancer: how close to personalized targeted therapy?Papillomavirus E6 proteins.Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins.HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers.Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness.A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells.
P2860
Q24305966-B5ED1615-2EA2-421D-8A0F-BEC742557346Q27007473-C022E261-67CB-4BF9-8FAB-EFD7B092E62FQ30410553-7861003F-2A13-4F71-A77A-D0AC34532AF2Q30421662-735D91E8-E027-4248-9B30-38ECDEA4BDD5Q34683991-DF09CBCB-2526-4EF9-ADFF-C9F89B65D5B8Q35098322-1EEE12E9-A11C-4477-90FB-E4E1800744BCQ35107717-E142BC6D-72E4-4068-8161-077C4C6129CEQ35785387-6ABB9EA3-DA25-4FAC-8C64-7C178111966FQ36284493-D8486947-9A21-4D14-8CE2-D5296EF838CAQ36473674-8D2F294D-4D59-4D5B-B30F-2CCE5B74874EQ36898915-106C0466-10D1-40C4-AC23-47860F877C9CQ37000422-EC20EC98-EBBF-4359-B5CE-84A4D7A7D042Q37350446-6C9DDB71-A784-4092-8439-F3B731176211Q37419555-942BB87F-A07A-45B1-97B7-3EF3E12417C4Q38149333-290B5790-BAAB-4765-8F11-027DC4404041Q39191981-B09BF207-6EB1-4F96-A489-9C5394E020D9Q47251663-8ED89338-81E5-4C8C-B970-B09475CC7FA0Q55038212-DDFF6A2D-00A8-4B95-AF8D-2AEB4B174C75
P2860
Inhibition of E6-induced degradation of its cellular substrates by novel blocking peptides.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Inhibition of E6-induced degra ...... es by novel blocking peptides.
@ast
Inhibition of E6-induced degra ...... es by novel blocking peptides.
@en
type
label
Inhibition of E6-induced degra ...... es by novel blocking peptides.
@ast
Inhibition of E6-induced degra ...... es by novel blocking peptides.
@en
prefLabel
Inhibition of E6-induced degra ...... es by novel blocking peptides.
@ast
Inhibition of E6-induced degra ...... es by novel blocking peptides.
@en
P2093
P1476
Inhibition of E6-induced degra ...... es by novel blocking peptides.
@en
P2093
Heather Griffin
Helena Sterlinko Grm
John Doorbar
Lawrence Banks
Malte Weber
Pauline McIntosh
Rob Elston
P304
P356
10.1016/J.JMB.2003.10.079
P407
P577
2004-01-01T00:00:00Z